{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:05:31Z","timestamp":1767143131890,"version":"build-2238731810"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12282-018-0904-2","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T04:53:56Z","timestamp":1536209636000},"page":"154-163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5796-5781","authenticated-orcid":false,"given":"Soha","family":"Talima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hebatallah","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neemat","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,6]]},"reference":[{"key":"904_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IJGM.S119301","volume":"10","author":"A Elgharably","year":"2017","unstructured":"Elgharably A, Gomaa AI, Crossey MM, Norsworthy PJ, Waked I, Taylor-Robinson SD. Hepatitis C in Egypt\u2014past, present, and future. Int J Gen Med. 2017;10:1\u20136. https:\/\/doi.org\/10.2147\/IJGM.S119301 (Published online 2016 Dec 20).","journal-title":"Int J Gen Med."},{"issue":"4","key":"904_CR2","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jhep.2015.04.021","volume":"63","author":"RD Allison","year":"2015","unstructured":"Allison RD, Tong X, Moorman AC, Ly KN, Rupp L, Xu F,et al. Chronic Hepatitis Cohort Study (CHeCS) Investigators. Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006\u20132010. J Hepatol. 2015;63(4):822\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2015.04.021 .","journal-title":"J Hepatol"},{"issue":"5","key":"904_CR3","doi-asserted-by":"publisher","first-page":"E35986","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359\u201386. https:\/\/doi.org\/10.1002\/ijc.29210 .","journal-title":"Int J Cancer"},{"key":"904_CR4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.26719\/2003.9.3.448","volume":"9","author":"S Omar","year":"2003","unstructured":"Omar S, Khaled H, Gaafar R, Zekry AR, Eissa S, el-Khatib O. Breast cancer in Egypt: a review of disease presentation and detection strategies. East Mediterr Health J 2003;9:448\u201363.","journal-title":"East Mediterr Health J"},{"key":"904_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/cas.12647","volume":"106","author":"H Kenmotsu","year":"2015","unstructured":"Kenmotsu H, Tanigawara Y. Pharmacokinetics, dynamics and toxicity of docetaxel: why the Japanese dose differs from the western dose. Cancer Sci. 2015;106:497\u2013504. https:\/\/doi.org\/10.1111\/cas.12647 .","journal-title":"Cancer Sci"},{"key":"904_CR6","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/apt.12324","volume":"37","author":"JH Lewis","year":"2013","unstructured":"Lewis JH, Stine JG. Review article: prescribing medications in patients with cirrhosis a practical guide. Aliment Pharmacol Ther. 2013;37:1132\u201356. https:\/\/doi.org\/10.1111\/apt.12324 .","journal-title":"Aliment Pharmacol Ther"},{"key":"904_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.7150\/jca.6231","volume":"4","author":"Y Miura","year":"2013","unstructured":"Miura Y, Theriault RL, Naito Y, Suyama K, Shimomura A, Iwatani T, et al. The safety of chemotherapy for breast cancer patients with hepatitis C virus infection. J Cancer. 2013;4:519\u201323. https:\/\/doi.org\/10.7150\/jca.6231 .","journal-title":"J Cancer"},{"key":"904_CR8","first-page":"419","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene F, Trotti A, et al. AJCC cancer staging manual, 7th ed. New York: Springer; 2010. p.\u00a0419\u201360.","edition":"7"},{"key":"904_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/PAI.0b013e31822a8eac","volume":"19","author":"ME Hammond","year":"2011","unstructured":"Hammond ME. ASCO-CAP guidelines for breast predictive factor testing: an update. App Immunohistochem Mol Morphol 2011;19:499\u2013500. https:\/\/doi.org\/10.1097\/PAI.0b013e31822a8eac .","journal-title":"App Immunohistochem Mol Morphol"},{"key":"904_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/jcp.53.5.374","volume":"53","author":"S Wang","year":"2000","unstructured":"Wang S, Saboorian MH, Frenkel E, Hynan L, Gokaslan S, Ashfaq R, et al. Laboratory assessment of the status of Her-2\/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridization assays. J Clin Pathol. 2000;53:374\u201381. https:\/\/doi.org\/10.1136\/jcp.53.5.374 .","journal-title":"J Clin Pathol"},{"key":"904_CR11","unstructured":"Common Terminology Criteria for Adverse. Events (CTCAE) version 4.0 pdf. http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-0614_QuickReference_8.5x11.pdf . Accessed 19 Mar 2017"},{"key":"904_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646\u20139. https:\/\/doi.org\/10.1002\/bjs.1800600817 .","journal-title":"Br J Surg"},{"key":"904_CR13","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1086\/605561","volume":"49","author":"BH McGovern","year":"2009","unstructured":"McGovern BH, Birch CE, Bowen MJ, Reyor LL, Nagami EH, Chung RT, et al. Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. Clin Infect Dis. 2009;49:1051\u201360. https:\/\/doi.org\/10.1086\/605561 .","journal-title":"Clin Infect Dis"},{"key":"904_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1385\/MO:21:1:67","volume":"21","author":"M Ozguroglu","year":"2004","unstructured":"Ozguroglu M, Bilici A, Turna H, Serdengecti S. Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin\u2019s lymphoma. Med Oncol. 2004;21:67\u201372. https:\/\/doi.org\/10.1385\/MO:21:1:67 .","journal-title":"Med Oncol"},{"key":"904_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMra052270","volume":"354","author":"VJ Navarro","year":"2006","unstructured":"Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006;354:731\u20139. https:\/\/doi.org\/10.1056\/NEJMra052270 .","journal-title":"N Engl J Med"},{"key":"904_CR16","first-page":"507","volume":"56","author":"K Nakagawa","year":"1996","unstructured":"Nakagawa K, Miller FN, Sims DE, Lentsch AB, Miyazaki M, Edwards MJ. Mechanisms of interleukin-2-induced hepatic toxicity. Cancer Res. 1996;56:507\u201310.","journal-title":"Cancer Res"},{"key":"904_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.clon.2003.11.015","volume":"16","author":"ME Melisko","year":"2004","unstructured":"Melisko ME, Fox R, Venook A. Reactivation of hepatitis C virus after chemotherapy for colon cancer. Clinical oncology. 2004;16:204\u20135.","journal-title":"Clinical oncology"},{"key":"904_CR18","first-page":"162","volume":"21","author":"D Santini","year":"2003","unstructured":"Santini D, Picardi A, Vincenzi B, et al. Severe liver dysfunction after raltitrexed administration in an HCV-positive colorectal cancer patient. Clin Oncol. 2003;21:162.","journal-title":"Clin Oncol"},{"key":"904_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2796.1993.tb00734.x","volume":"234","author":"A Gruber","year":"1993","unstructured":"Gruber A, Lundberg LG, Bjorkholm M. Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy. J Intern Med. 1993;234:223\u20135.","journal-title":"J Intern Med"},{"key":"904_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1600-0609.2004.00376.x","volume":"74","author":"S Takai","year":"2005","unstructured":"Takai S, Tsurumi H, Ando K, et al. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol. 2005;74:158\u201365.","journal-title":"Eur J Haematol"},{"issue":"4","key":"904_CR21","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3892\/mmr.2014.1973","volume":"9","author":"L Xu","year":"2014","unstructured":"Xu L, Tu Z, Xu G, Wang Y, Pan W, Zhan X, et al. Epirubicin directly promotes hepatitis B virus (HBV) replication in stable HBV-expressing cell lines: a novel mechanism of HBV reactivation following anticancer chemotherapy. Mol Med Rep. 2014;9(4):1345\u201350. https:\/\/doi.org\/10.3892\/mmr.2014.1973 . (Epub 2014 Feb 20).","journal-title":"Mol Med Rep."},{"issue":"6","key":"904_CR22","doi-asserted-by":"publisher","first-page":"870","DOI":"10.5009\/gnl16434","volume":"11","author":"HL Lee","year":"2017","unstructured":"Lee HL, Bae SH, Jang B, et al. Reactivation of hepatitis C virus and its clinical outcomes in patients treated with systemic chemotherapy or immunosuppressive therapy. Gut Liver. 2017;11(6):870\u20137. https:\/\/doi.org\/10.5009\/gnl16434.) .","journal-title":"Gut Liver"},{"key":"904_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/hep.24689","volume":"55","author":"H Doi","year":"2012","unstructured":"Doi H, Iyer TK, Carpenter E, et al. Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population. Hepatology. 2012;55:709\u201319.","journal-title":"Hepatology"},{"issue":"13","key":"904_CR24","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1111\/hepr.12919","volume":"47","author":"A Doi","year":"2017","unstructured":"Doi A, Sakamori R, Tahata Y, Urabe A, Morishita N, Yamada R, et al. Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all-oral direct-acting antivirals: Analysis of a Japanese prospective cohort. Hepatol Res. 2017 Dec;47(13):1438\u201344. https:\/\/doi.org\/10.1111\/hepr.12919 . (Epub 2017 Aug 1).","journal-title":"Hepatol Res"},{"issue":"1","key":"904_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/hep.29344","volume":"67","author":"HA Torres","year":"2018","unstructured":"Torres HA, Hosry J, Mahale P, Economides MP, Jiang Y, Lok AS. Hepatitis C virus reactivation in patients with cancer: a prospective observational study. Hepatology. 2018;67(1):36\u201347. https:\/\/doi.org\/10.1002\/hep.29344 .","journal-title":"Hepatology"},{"key":"904_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0192-0561(99)00005-3","volume":"21","author":"N Magy","year":"1999","unstructured":"Magy N, Cribier B, Schmitt C, Ellero B, Jaeck D, Boudjema K, et al. Effects of corticosteroids on HCV infection. Int J Immunopharmacol. 1999;21:253\u201361.","journal-title":"Int J Immunopharmacol"},{"key":"904_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/0016-5085(94)90077-9","volume":"107","author":"TL Fong","year":"1994","unstructured":"Fong TL, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology. 1994;107:196\u20139.","journal-title":"Gastroenterology"},{"key":"904_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajme.2014.08.001","volume":"51","author":"KY Welaya","year":"2015","unstructured":"Welaya KY, El-Assal S, Salama OE, Ghanem HM, Abdelmoneim SE. The effect of HCV serological status on Doxorubicin based chemotherapy induced toxicity and disease-free survival in breast cancer patients. Alex J Med. 2015;51:287\u201393. https:\/\/doi.org\/10.1016\/j.ajme.2014.08.001 .","journal-title":"Alex J Med"},{"key":"904_CR29","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/annonc\/mdp458","volume":"21","author":"PK Morrow","year":"2010","unstructured":"Morrow PK, Tarrand JJ, Taylor SH, Kau SW, Theriault RL, Hortobagyi GN, et al. Effects of chronic hepatitis C infection on the treatment of breast cancer patients. Ann Oncol. 2010;21:1233\u20136. https:\/\/doi.org\/10.1093\/annonc\/mdp458 .","journal-title":"Ann Oncol"},{"key":"904_CR30","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/apt.13825","volume":"44","author":"MP Economides","year":"2016","unstructured":"Economides MP, Mahale P, Kyvernitakis A, et al. Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer. Aliment Pharmacol Ther. 2016;44:1235\u201341.","journal-title":"Aliment Pharmacol Ther"},{"key":"904_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10549-017-4259-8","volume":"164","author":"Y Liu","year":"2017","unstructured":"Liu Y, Li ZY, Wang JN, Li X, Huang QA, Huang Y. Effects of hepatitis C virus infection on the safety of chemotherapy for breast cancer patients. Breast Cancer Res Treat. 2017;164:379\u201383. https:\/\/doi.org\/10.1007\/s10549-017-4259-8 .","journal-title":"Breast Cancer Res Treat"}],"updated-by":[{"DOI":"10.1007\/s12282-018-0909-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:00:00Z","timestamp":1537488000000}}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-018-0904-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-018-0904-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-018-0904-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T16:43:37Z","timestamp":1661964217000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-018-0904-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,6]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1007\/s12282-018-0904-2","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,6]]},"assertion":[{"value":"20 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}